Download FREE Report Sample
Download Free sampleAntibody Drug Conjugates Contract Market contains market size and forecasts of Antibody Drug Conjugates Contract Manufacturing in Global, including the following market information:
Global Antibody Drug Conjugates Contract Manufacturing Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Antibody Drug Conjugates Contract Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
IgG1 Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Antibody Drug Conjugates Contract Manufacturing include Lonza Group, Piramal Pharma Solutions, Abbvie, Novasep, Merck, Cambrex Corporation, Recipharm, Thermo Fisher Scientific and Cerbios-Pharma, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Drug Conjugates Contract Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Drug Conjugates Contract Manufacturing Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Antibody Drug Conjugates Contract Manufacturing Market Segment Percentages, by Type, 2022 (%)
IgG1
IgG2
IgG4
Global Antibody Drug Conjugates Contract Manufacturing Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Antibody Drug Conjugates Contract Manufacturing Market Segment Percentages, by Application, 2022 (%)
Solid Tumors
Hematological Malignancies
Global Antibody Drug Conjugates Contract Manufacturing Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Antibody Drug Conjugates Contract Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibody Drug Conjugates Contract Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antibody Drug Conjugates Contract Manufacturing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza Group
Piramal Pharma Solutions
Abbvie
Novasep
Merck
Cambrex Corporation
Recipharm
Thermo Fisher Scientific
Cerbios-Pharma
Sterling Pharma Solutions
ADC Biotechnology
Ajinomoto Bio-Pharma Services
BOC Sciences
BSP Pharmaceuticals
CARBOGEN AMCIS
Goodwin Biotechnology
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy